Public Joint-Stock Company Human Stem Cells Institute announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was RUB 556.754 million compared to RUB 453.153 million a year ago. Operating income was RUB 65.721 million compared to RUB 137.151 million a year ago. Net income was RUB 19.712 million compared to RUB 72.434 million a year ago. Basic earnings per share from continuing operations was RUB 0.26 compared to RUB 0.97 a year ago.